News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
64,841 Results
Type
Article (2438)
Company Profile (60)
Press Release (62343)
Section
Business (28671)
Career Advice (42)
Deals (4601)
Drug Delivery (4)
Drug Development (6331)
FDA (1057)
Job Trends (1392)
News (38876)
Policy (1943)
Tag
Academia (99)
Accelerated approval (4)
Adcomms (3)
Allergies (6)
Alliances (2134)
ALS (13)
Alzheimer's disease (151)
Antibody-drug conjugate (ADC) (31)
Approvals (1133)
Artificial intelligence (41)
Autoimmune disease (13)
Automation (3)
Bankruptcy (8)
Best Places to Work (1342)
BIOSECURE Act (3)
Biosimilars (12)
Biotechnology (37)
Bladder cancer (45)
Brain cancer (2)
Breast cancer (94)
Cancer (561)
Cardiovascular disease (46)
Career advice (40)
Career pathing (1)
CAR-T (19)
Cell therapy (47)
Cervical cancer (4)
Clinical research (5927)
Collaboration (105)
Compensation (118)
Complete response letters (2)
COVID-19 (160)
CRISPR (6)
C-suite (33)
Cystic fibrosis (13)
Data (743)
Depression (6)
Diabetes (68)
Diagnostics (682)
Digital health (5)
Drug discovery (14)
Drug pricing (11)
Duchenne muscular dystrophy (11)
Earnings (26961)
Editorial (1)
Events (7773)
Executive appointments (34)
FDA (1503)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (8)
Funding (63)
Gene editing (8)
Generative AI (2)
Gene therapy (21)
GLP-1 (93)
Government (188)
Guidances (239)
Healthcare (1951)
HIV (9)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (14)
Immuno-oncology (3)
Indications (6)
Infectious disease (183)
Inflammatory bowel disease (17)
Influenza (6)
Intellectual property (16)
Interviews (1)
IPO (3506)
Job creations (131)
Job search strategy (38)
Kidney cancer (5)
Labor market (5)
Layoffs (27)
Legal (334)
Liver cancer (13)
Lung cancer (96)
Lymphoma (64)
Machine learning (2)
Manufacturing (27)
MASH (27)
Medical device (1575)
Medtech (1584)
Mergers & acquisitions (1226)
Metabolic disorders (159)
Multiple sclerosis (33)
NASH (2)
Neurodegenerative disease (20)
Neuropsychiatric disorders (6)
Neuroscience (281)
NextGen: Class of 2026 (407)
Non-profit (163)
Now hiring (2)
Obesity (64)
Opinion (2)
Ovarian cancer (18)
Pain (19)
Pancreatic cancer (30)
Parkinson's disease (31)
Patents (27)
Patient recruitment (27)
Peanut (4)
People (2002)
Pharmaceutical (12)
Pharmacy benefit managers (2)
Phase 1 (1479)
Phase 2 (2454)
Phase 3 (2467)
Pipeline (1313)
Policy (5)
Postmarket research (222)
Preclinical (466)
Press Release (1)
Prostate cancer (12)
Psychedelics (4)
Radiopharmaceuticals (29)
Rare diseases (57)
Real estate (223)
Regulatory (1722)
Reports (2)
Research institute (101)
Resumes & cover letters (2)
Rett syndrome (3)
RSV (7)
Schizophrenia (14)
Series A (11)
Series B (10)
Service/supplier (2)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (15)
Sponsored (1)
Startups (133)
Stomach cancer (3)
Supply chain (4)
The Weekly (2)
Vaccines (52)
Venture capital (3)
Weight loss (46)
Women's health (6)
Worklife (1)
Date
Today (13)
Last 7 days (85)
Last 30 days (272)
Last 365 days (3930)
2026 (401)
2025 (3978)
2024 (4622)
2023 (5247)
2022 (5849)
2021 (6253)
2020 (5742)
2019 (4025)
2018 (3089)
2017 (2723)
2016 (2141)
2015 (2914)
2014 (1811)
2013 (1184)
2012 (1356)
2011 (1659)
2010 (1630)
Location
Africa (58)
Alabama (5)
Alaska (1)
Arizona (18)
Arkansas (1)
Asia (4213)
Australia (785)
California (1614)
Canada (421)
China (92)
Colorado (83)
Connecticut (51)
Delaware (54)
Europe (8474)
Florida (194)
Georgia (47)
Idaho (3)
Illinois (84)
India (5)
Indiana (75)
Japan (81)
Kansas (12)
Kentucky (5)
Louisiana (7)
Maine (13)
Maryland (233)
Massachusetts (877)
Michigan (52)
Minnesota (71)
Missouri (14)
Montana (7)
Nebraska (1)
Nevada (16)
New Hampshire (7)
New Jersey (450)
New York (337)
North Carolina (179)
Northern California (807)
Ohio (24)
Oregon (3)
Pennsylvania (291)
Puerto Rico (1)
Rhode Island (1)
South America (72)
Southern California (629)
Tennessee (13)
Texas (245)
United States (5226)
Utah (39)
Virginia (24)
Washington D.C. (5)
Washington State (193)
Wisconsin (9)
64,841 Results for "92".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
At $9.2 billion, the Cidara acquisition lands among the top 5 largest deals of the year.
November 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
December 15, 2025
·
5 min read
Press Releases
Active Pharmaceutical Ingredients CDMO Market Size Expected to Hit USD 273.92 Bn by 2034
October 13, 2025
·
1 min read
Press Releases
Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer
October 21, 2025
·
5 min read
Press Releases
CORRECTING and REPLACING Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer
October 28, 2025
·
5 min read
Alzheimer’s disease
Roche Is Back in Alzheimer’s as Latest Antibody Clears Amyloid Plaques
Trontinemab lowered amyloid levels below the threshold of positivity in 92% of treated patients.
December 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
September 16, 2025
·
6 min read
Biosimilars
Boehringer Ingelheim Partners With GoodRx to Offer Humira Biosimilar at 92% Discount
In a bid to take advantage of Humira’s slow loss of market share, Boehringer Ingelheim is offering its biosimilar at a 92% discount exclusively to patients who buy the product on GoodRx.
July 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Route 92 Medical Appoints Medtech Industry Veterans Mitch Hill and Lucas Buchanan to its Board of Directors
June 18, 2025
·
3 min read
Press Releases
Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
June 12, 2025
·
4 min read
1 of 6,485
Next
